BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 3595474)

  • 1. The evolution of non-steroidal anti-inflammatory drugs and their mechanisms of action.
    Vane J
    Drugs; 1987; 33 Suppl 1():18-27. PubMed ID: 3595474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of non-steroidal anti-inflammatory drugs on rat gastric mucosal leukotriene C4 and prostanoid release: relation to ethanol-induced injury.
    Peskar BM; Hoppe U; Lange K; Peskar BA
    Br J Pharmacol; 1988 Apr; 93(4):937-43. PubMed ID: 3390662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mode of action of anti-inflammatory drugs.
    Vane JR; Botting RM
    Postgrad Med J; 1990; 66 Suppl 4():S2-17. PubMed ID: 2126623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity.
    Cerletti C
    Int J Tissue React; 1985; 7(4):309-12. PubMed ID: 3934097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The modes of anti-inflammatory and analgesic actions of aspirin and salicylic acid].
    Higuchi S; Osada Y; Shioiri Y; Tanaka N; Otomo S; Aihara H
    Nihon Yakurigaku Zasshi; 1985 Jan; 85(1):49-57. PubMed ID: 3921440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and the mechanism of action of anti-inflammatory drugs.
    Vane J; Botting R
    FASEB J; 1987 Aug; 1(2):89-96. PubMed ID: 3111928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of action: aspirin.
    Hoak JC
    Thromb Res Suppl; 1983; 4():47-51. PubMed ID: 6415858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: additional evidence for distinct enzymatic sites.
    Rotilio D; Joseph D; Hatmi M; Vargaftig BB
    Eur J Pharmacol; 1984 Jan; 97(3-4):197-208. PubMed ID: 6423393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects of aspirin and sodium salicylate.
    Amann R; Peskar BA
    Eur J Pharmacol; 2002 Jun; 447(1):1-9. PubMed ID: 12106797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does non-acetylated salicylate inhibit thromboxane biosynthesis in human platelets?
    Danesh BJ; McLaren M; Russell RI; Lowe GD; Forbes CD
    Scott Med J; 1988 Aug; 33(4):315-6. PubMed ID: 3187504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.
    Dejana E; Cerletti C; de Castellarnau C; Livio M; Galletti F; Latini R; de Gaetano G
    J Clin Invest; 1981 Oct; 68(4):1108-12. PubMed ID: 6793630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acetaminophen and salicylate on aspirin-induced inhibition of human platelet cyclo-oxygenase.
    Rao GH; Reddy KR; White JG
    Prostaglandins Leukot Med; 1982 Jul; 9(1):109-15. PubMed ID: 6813873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance.
    Poorani R; Bhatt AN; Dwarakanath BS; Das UN
    Eur J Pharmacol; 2016 Aug; 785():116-132. PubMed ID: 26335394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity.
    Higgs GA; Salmon JA; Henderson B; Vane JR
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1417-20. PubMed ID: 3103135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiinflammatory action of salicylates: aspirin is not a prodrug for salicylate against rat carrageenin pleurisy.
    Chiabrando C; Castelli MG; Cozzi E; Fanelli R; Campoleoni A; Balotta C; Latini R; Garattini S
    Eur J Pharmacol; 1989 Jan; 159(3):257-64. PubMed ID: 2920775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drugs react with two sites on platelet cyclo-oxygenase. Evidence from "in vivo" drug interaction studies in rats.
    Cerletti C; Livio M; De Gaetano G
    Biochim Biophys Acta; 1982 Jan; 714(1):122-8. PubMed ID: 6799004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway.
    Siegel MI; McConnell RT; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):3774-8. PubMed ID: 115007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.